Perovskite luminescent nanocrystal, light emitting device, and manufacturing method for perovskite luminescent nanocrystal

Abstract

A perovskite luminescent nanocrystal has a chemical formula represented by: Cs.sub.4BX.sub.6, wherein B includes one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X includes one or more selected from the group consisting of Cl, Br, and I, wherein the Cs.sub.4BX.sub.6 perovskite luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs.sub.4BX.sub.6 perovskite luminescent nanocrystal is greater than 1 and less than 4.

Claims

1. A perovskite luminescent nanocrystal represented by a chemical formula of:
Cs.sub.4BX.sub.6, wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I, wherein the Cs.sub.4BX.sub.6 perovskite luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs.sub.4BX.sub.6 perovskite luminescent nanocrystal is greater than 1 and less than 4.

2. The perovskite luminescent nanocrystal of claim 1, wherein a size of the perovskite luminescent nanocrystal is smaller than 500 nm.

3. A light emitting device comprising: a light emitting element configured to emit blue light or ultraviolet light; and a light emitting material, wherein the light emitting material comprises the perovskite luminescent nanocrystal of claim 1, and the light emitting material is excited by the blue light or the ultraviolet light to emit first light rays.

4. The light emitting device of claim 3, wherein when the perovskite luminescent nanocrystal is Cs.sub.4PbBr.sub.6, the first light rays have a peak wavelength ranged from 500 nm to 540 nm and an FWHM ranged from 10 nm to 30 nm.

5. The light emitting device of claim 3, wherein the light emitting material further comprises one or more other wavelength converting materials.

6. The light emitting device of claim 5, wherein the one or more wavelength converting materials are excited by the blue light or the ultraviolet light to emit second light rays.

7. The light emitting device of claim 6, wherein a peak wavelength of the second light rays fall within a red wavelength range.

8. The light emitting device of claim 3, wherein the light emitting element is a light emitting diode chip, a sub-millimeter light emitting diode chip, or a micro light emitting diode chip.

9. A manufacturing method for a perovskite luminescent nanocrystal comprising steps of: forming a cesium (Cs)-containing oleic acid precursor; mixing the cesium-containing oleic acid precursor, a non-polar solvent, and a first nucleating agent to form a first solution; adding BX.sub.2, a polar solvent, and a second nucleating agent to the first solution to form a second solution, wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I; and stirring the second solution to form a perovskite luminescent nanocrystal represented by a chemical formula of:
Cs.sub.4BX.sub.6, wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I, wherein the Cs.sub.4BX.sub.6 perovskite luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs.sub.4BX.sub.6 perovskite luminescent nanocrystal is greater than 1 and less than 4 by using an elemental analysis.

10. The manufacturing method of claim 9, wherein the step of forming the cesium oleate precursor comprises: dissolving a cesium-containing precursor in oleic acid, wherein the cesium-containing precursor comprises cesium carbonate, cesium bromide, cesium oleylamine, or cesium oleate.

11. The manufacturing method of claim 9, wherein the second solution is stirred in a nitrogen condition at a room temperature to form the perovskite luminescent nanocrystal.

12. The manufacturing method of claim 9, wherein the step of forming the second solution further comprises adding a solubilizing agent, and the solubilizing agent is HX, wherein X is F, Cl, Br, or I.

13. The manufacturing method of claim 9, wherein each of the first nucleating agent and the second nucleating agent comprises oleic acid, oleylamine, or a combination thereof.

14. The manufacturing method of claim 9, wherein a polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 3 and less than or equal to 10.

15. The manufacturing method of claim 14, wherein when the polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 3 and less than 6, the perovskite luminescent nanocrystal has a particle size between 100 nm and 500 nm is formed.

16. The manufacturing method of claim 14, wherein when the polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 6 and less than or equal to 10, the perovskite luminescent nanocrystal has a particle size between 10 nm and 100 nm is formed.

17. The manufacturing method of claim 9, wherein the polar solvent is selected from the group consisting of isopropanol, Isobutyl alcohol, tetrafuran, water, acetone, methanol, ethanol, ethylene glycol, n-propanol, n-butanol, ethyl acetate, acetonitrile, dimethyl formamide, and dimethyl sulfoxide, and the non-polar solvent is selected from the group consisting of n-pentane, hexane, cyclohexane, benzene, toluene, p-xylene, and chlorobenzene.

18. The manufacturing method of claim 9, wherein the elemental analysis comprises an energy-dispersive X-ray spectroscopy measurement, an inductively coupled plasma atomic emission spectroscopy measurement, or an inductively coupled plasma mass spectrometry measurement.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) The accompanying drawings are included to provide a further understanding of the invention, and are incorporated in and constitute a part of this specification. The drawings illustrate embodiments of the invention and, together with the description, serve to explain the principles of the invention. In the drawings,

(2) FIG. 1 depicts a flowchart of steps of a manufacturing method for a perovskite luminescent nanocrystal according to one embodiment of this invention;

(3) FIG. 2A is a scanning electron microscope image of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to one embodiment of the present invention;

(4) FIG. 2B is a transmission electron microscopy image of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to one embodiment of the present invention;

(5) FIG. 2C is a structural model of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to one embodiment of the present invention;

(6) FIG. 2D is an energy-dispersive X-ray spectroscopy diagram of a pure-phase CsPbBr.sub.3 perovskite nanocrystal of a comparative example of the present invention;

(7) FIG. 2E is a relationship diagram showing a Cs/Pb molar ratio of pure-phase Cs.sub.4PbBr.sub.6 at different precursor synthesis ratios and measured by an energy dispersive X-ray spectroscopy according to one embodiment of the present invention;

(8) FIG. 3 is a synchrotron X-ray diffraction diagram of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to one embodiment of the present invention;

(9) FIG. 4 is a photoluminescence excited spectrum and a photoluminescence emission spectrum of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to one embodiment of the present invention;

(10) FIG. 5A is temperature-dependent photoluminescence spectra of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to one embodiment of the present invention;

(11) FIG. 5B is temperature-dependent photoluminescence spectra of a CsPbBr.sub.3 perovskite luminescent nanocrystal according to a comparative example of the present invention;

(12) FIG. 6 is X-ray diffraction diagrams of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal varied with a Cs/Pb ratio according to one embodiment of the present invention;

(13) FIG. 7 is an external quantum efficiency diagram of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal varied with a Cs/Pb ratio according to the present invention; and

(14) FIG. 8 depicts a cross-sectional schematic diagram of a light emitting device according to some embodiments of the present invention.

DESCRIPTION OF THE EMBODIMENTS

(15) Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the relevant art in the context of the present disclosure, and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.

(16) The terms about and approximately in the disclosure are used as equivalents. Any numerals used in this disclosure with or without about, approximately, etc. are meant to cover any normal fluctuations appreciated by one of ordinary skill in the relevant art. In certain embodiments, the term approximately or about refers to a range of values that fall within 20%, 10%, 5%, or less in either direction (greater or less than) of the stated reference value unless otherwise stated or otherwise evident from the context.

(17) FIG. 1 is a flowchart illustrating a method 10 for manufacturing a perovskite luminescent nanocrystal according to one embodiment of this invention. As shown in FIG. 1, the manufacturing method 10 comprises steps S1, S2, S3, and S4.

(18) In step S1, a cesium oleate precursor is formed. In greater detail, a cesium-containing precursor is dissolved in oleic acid in some embodiments. For example, the cesium-containing precursor comprises cesium carbonate (Cs.sub.2CO.sub.3), cesium bromide (CsBr), cesium oleylamine (CsOAm), or cesium oleate (Cs-oleate).

(19) In step S2, the cesium-containing oleic acid precursor, a non-polar solvent, and a first nucleating agent are mixed together to form a first solution. In various embodiments, the non-polar solvent is selected from the group consisting of n-pentane, hexane, cyclohexane, benzene, toluene, p-xylene, and chlorobenzene. In various embodiments, the first nucleating agent comprises oleic acid, oleylamine, or a combination thereof.

(20) In step S3, BX.sub.2, a polar solvent, and a second nucleating agent are added to the first solution to form a second solution. Here B comprises one or more selected from the group consisting of germanium (Ge), lead (Pb), tin (Sn), antimony (Sb), bismuth (Bi), copper (Cu), and manganese (Mn), and X comprises one or more selected from the group consisting of chlorine (Cl), bromine (Br), and iodine (I). In various embodiments, the polar solvent is selected from the group consisting of isopropanol, isobutyl alcohol, tetrafuran, water, acetone, methanol, ethanol, ethylene glycol, n-propanol, n-butanol, ethyl acetate, acetonitrile, dimethyl formamide (DMF), and dimethyl sulfoxide. It is noted that a polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 3 and less than or equal to 10 according to the present embodiment. The polarity difference refers to a polarity index of the polar solution minus a polarity index of the non-polar solution. In various embodiments, the second nucleating agent comprises oleic acid, oleylamine, or a combination of oleic acid and oleylamine.

(21) Please refer to the polarity indexes of solvents shown in Table 1 as follows, which lists polarity indexes of commonly used polar solvents and non-polar solvents. Therefore, the suitable polar solvent and non-polar solvent can be selected based on the requirement that the polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 3 and less than or equal to 10.

(22) TABLE-US-00001 TABLE 1 Solvent Name Polarity Index n-pentane 0 Hexane 0.06 cyclohexane 0.1 Toluene 2.4 p-xylene 2.5 Chlorobenzene 2.7 Benzene 3 Isobutyl alcohol 3 n-butanol 3.7 Tetrafuran 4.2 Ethyl acetate 4.3 Isopropanol 4.3 Chloroform 4.4 Acetone 5.4 Acetic acid 6.2 Acetonitrile 6.2 Dimethyl formamide (DMF) 6.4 Methanol 6.6 Ethylene glycol 6.9 Dimethyl sulfoxide 7.2 Water 10.2

(23) In some embodiments, the step of forming the second solution may further comprise adding a solubilizing agent. In detail, BX.sub.2, the polar solvent, the second nucleating agent, and the solubilizing agent may be added to the first solution so as to form the second solution. For example, the solubilizing agent is HX, wherein X is fluorine (F), chlorine (Cl), bromine (Br), or iodine (I).

(24) In step S4, the second solution is stirred after the step of forming the second solution so as to form the perovskite luminescent nanocrystal. The perovskite luminescent nanocrystal has a chemical formula represented by: Cs.sub.4BX.sub.6, wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I, wherein the Cs.sub.4BX.sub.6 luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) in the Cs.sub.4BX.sub.6 luminescent nanocrystal is greater than 1 and less than 4 after an elemental analysis. The elemental analysis method used may be an energy-dispersive X-ray spectroscopy (EDS) measurement, an inductively coupled plasma atomic emission spectroscopy (ICP-AES) measurement, an inductively coupled plasma mass spectrometry (ICP-MS) measurement, or other element identification methods. In the present embodiment, the second solution can be stirred in a nitrogen condition at room temperature. The room temperature may be from 20 C. to 30 C., for example, may be 22 C., 24 C., 26 C., or 28 C. In one embodiment, when the polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 3 and less than 6, the perovskite luminescent nanocrystal having a particle size between 100 nm and 500 nm can be formed. In another embodiment, when the polarity difference between the polar solvent and the non-polar solvent is greater than or equal to 6 and less than or equal to 10, the perovskite luminescent nanocrystal having a particle size between 10 nm and 100 nm can be formed.

(25) A detailed operation example of a Cs.sub.4BX.sub.6 perovskite luminescent nanocrystal manufactured by the micro-emulsion method is provided as follows. First, 6.9 mmol of Cs.sub.2CO.sub.3 and 21.5 mL of oleic acid are added to a 50 mL three-necked flask, and water is removed in a vacuum at 130 C. for one hour, and then being placed in a nitrogen atmosphere at a temperature of 130 C. to form a cesium oleate precursor. After that, 1 mL of the cesium oleate precursor, 10 mL of toluene, and 5 mL of oleic acid are added to a 50 mL three-necked flask to form a first solution. Next, after washing the first solution with nitrogen for 30 minutes, 0.15 mmol of PbX.sub.2 (wherein X is chlorine (Cl), bromine (Br), and/or iodine (I)), 15 L of 48% HBr, 0.5 mL of oleic acid, and 0.5 mL of oleylamine are added to form a second solution. The mixture is gently stirred at room temperature of 20 C. to 30 C. in a nitrogen atmosphere for 30 minutes to wait for the formation of the Cs.sub.4BX.sub.6 perovskite luminescent nanocrystal. Finally, after centrifuging the solution at 8000 rpm for 6 minutes, the crystal product is reserved in 5 mL of toluene solution.

(26) As mentioned in the above operation example, in one experiment of the present invention, dimethyl formamide (DMF) of Table 1 with a polarity index of about 6.4 is selected as the polar solution, and toluene of Table 1 with a polarity index of about 2.4 is selected as the non-polar solution. The polarity difference between the two is about 4, and the Cs.sub.4BX.sub.6 perovskite luminescent nanocrystal having a particle size between 100 nm and 500 nm can be obtained.

(27) One aspect of the present invention is to provide a perovskite luminescent nanocrystal. The perovskite luminescent nanocrystal has a chemical formula represented by: Cs.sub.4BX.sub.6, wherein B comprises one or more selected from the group consisting of Ge, Pb, Sn, Sb, Bi, Cu, and Mn, and X comprises one or more selected from the group consisting of Cl, Br, and I. It is noted that the Cs.sub.4BX.sub.6 luminescent nanocrystal has a pure phase, and a molar ratio of Cs to B (Cs/B) is greater than 1 and less than 4. The molar ratio of Cs to B (Cs/B) can be obtained by using an energy-dispersive X-ray spectroscopy (EDS), an inductively coupled plasma atomic emission spectroscopy (ICP-AES), an inductively coupled plasma mass spectrometry (ICP-MS), or other element identification methods.

(28) FIG. 2A is a scanning electron microscope (SEM) image of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to one embodiment of the present invention. FIG. 2B is a transmission electron microscopy (TEM) image of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to one embodiment of the present invention. As can be seen from FIG. 2A and FIG. 2B, an average size of the perovskite luminescent nanocrystal is smaller than 500 nm, for example, 100 nm to 500 nm and/or 10 nm to 100 nm.

(29) FIG. 2C depict a structural model of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to one embodiment of the present invention. FIG. 2D is an energy-dispersive X-ray spectroscopy (EDS) diagram of a pure phase CsPbBr.sub.3 perovskite nanocrystal of a comparative example of the present disclosure. The weight percentage and atomic percentage of each element analyzed based on FIG. 2D are shown in Table 2 as follows.

(30) TABLE-US-00002 TABLE 2 Atomic Percentage Element Name Weight Percentage (%) (%) Br 36.97 55.76 Cs 23.38 21.19 Pb 39.65 23.05 Sum 100.00
It is noted that the working principle of energy dispersive X-ray spectroscopy is that different elements emit X-rays of different energies (wavelengths), and X-rays of different energies (wavelengths) are also emitted with transitions between different electron orbitals. For example, the orbital electron of the outer layer of the bromine (Br) atom leaps into the hole of the inner layer orbital (K layer) to emit X-rays. Similarly, the orbital electron of each of the Cs atom and the Pb atom leaps from the outer orbital into the hole of the inner orbit (L layer) to emit X-rays of different energies (wavelengths). As can be seen from FIG. 2D and table 2, the real composition of CsPbBr.sub.3 perovskite nanocrystals is CsPb.sub.0.9Br.sub.2.9, which is quite consistent with CsPbBr.sub.3. FIG. 2E is a relationship diagram showing a Cs/Pb molar ratio of pure-phase Cs.sub.4PbBr.sub.6 at different precursor synthesis ratios, measured by an energy dispersive X-ray spectroscopy according to one embodiment of the present invention. As can be seen by summarizing FIG. 2C to FIG. 2E, the actual molar ratio of Cs to Pb (Cs/Pb) is between 1 and 4 in the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal, which is not the theoretical Cs/Pb ratio of 4. This is because of the ratio difference caused by cationic defects in the Cs.sub.4PbBr.sub.6 perovskite nanocrystals. The cationic defects may be Cs ion defects, Pb ion defects, or both Cs ion defects and Pb ion defects. The cationic defects will cause the CsPb bonds originally connected between the PbBr.sub.6.sup.4 octahedrons to disappear, and induce the neighboring PbBr.sub.6.sup.4 octahedrons to gather so as to form three-dimensional halogen-shared CsPbBr.sub.3 clusters (also called clusters). Owing to the existence of the CsPbBr.sub.3 clusters, the molar ratio of Cs to Pb (Cs/Pb) of the pure-phase Cs.sub.4PbBr.sub.6 nanocrystal is greater than 1 and less than 4 after an elemental analysis. The elemental analysis method used may be an energy-dispersive X-ray spectroscopy (EDS) measurement, an inductively coupled plasma atomic emission spectroscopy (ICP-AES) measurement, an inductively coupled plasma mass spectrometry (ICP-MS) measurement, or other element identification methods.

(31) FIG. 3 is a synchrotron X-ray diffraction (XRD) diagram of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to the present invention. The data points A in FIG. 3 are diffraction data of the above Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal synthesized by the micro-emulsion method. Curve B is the fitting curve of the plurality of data points A. Curve C is the difference between the data points A and the curve B. Spectrum D is the standard diffraction spectrum of Cs.sub.4BX.sub.6. As can be seen from the XRD diagram of FIG. 3, the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal synthesized by the micro-emulsion method does not show any impure phase, and it is thus understood that it is pure-phase Cs.sub.4PbBr.sub.6. In addition, through structural calculation, it can be confirmed that the lattice parameters of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal belong to the rhombohedral crystal system (or called the trigonal crystal system), and a=b=13.72939(15) , and c=17.31874 (25) , here a, b, and c are lengths of three sides of the crystal lattice, which are generally called lengths of axes. In addition, as can be seen from FIG. 3, the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to the present embodiment is a pure-phase crystal.

(32) FIG. 4 is a photoluminescence excited spectrum (PLE) and a photoluminescence emission spectrum (PL) of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to the present invention. Curve PLE in FIG. 4 is the photoluminescence excited spectrum of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal, and curve PL is the photoluminescence emission spectrum of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal. As can be seen from FIG. 4, the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal has a broad excitation wavelength from 340 nm to 500 nm. The photoluminescence emission spectrum of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal has an emission center wavelength of 525 nm and an FWHM of 26 nm, thus rendering the photoluminescence emission spectrum of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal to present an extremely narrow line spectral structure. That is, the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal with an extremely narrow FWHM has extremely high color purity.

(33) FIG. 5A is temperature-dependent photoluminescence spectra (TL) of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal according to the present invention. Curve E in FIG. 5A is the photoluminescence intensity curve of the unbaked Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal. Curve F is the photoluminescence intensity curve after baking the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal at 100 C. for 10 minutes. Curve G is the photoluminescence intensity curve after baking the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal at 150 C. for 10 minutes. As can be seen from FIG. 5A, the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal after being baked at a high temperature still maintains 97% of the photoluminescence intensity as compared with the curve E of the unbaked Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal. It is thus understood that the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal has excellent heat resistance (or thermal stability).

(34) FIG. 5B is temperature-dependent photoluminescence spectra (TL) of a CsPbBr.sub.3 perovskite luminescent nanocrystal according to a comparative example of the present disclosure. Curve H in FIG. 5B is the photoluminescence intensity curve of the unbaked CsPbBr.sub.3 perovskite luminescent nanocrystal. Curve I is the photoluminescence intensity curve after baking the CsPbBr.sub.3 perovskite luminescent nanocrystal at 100 C. for 10 minutes. Curve J is the photoluminescence intensity curve after baking the CsPbBr.sub.3 perovskite luminescent nanocrystal at 150 C. for 10 minutes. As can be seen from FIG. 5B, only 62% of the photoluminescence intensity after the CsPbBr.sub.3 perovskite luminescent nanocrystal is baked at a high temperature is left as compared with the curve H of the unbaked Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal. It is thus understood that the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal has better heat resistance (or thermal stability) when compared with the CsPbBr.sub.3 perovskite luminescent nanocrystal.

(35) FIG. 6 is X-ray diffraction (XRD) diagrams of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal varied with a Cs/Pb ratio according to the present invention. As can be seen from FIG. 6, the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal synthesized with different Cs/Pb ratios does not show any impure phase when the Cs/Pb ratio is greater than or equal to 2.5. It is thus understood that when the Cs/Pb ratio is greater than or equal to 2.5, the Cs.sub.4PbBr.sub.6 has a pure phase. When the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal is synthesized with a Cs/Pb ratio equal to 2.25, weak diffraction noises can be observed at around 22.4. After being compared with the standard diffraction data, these noises are diffraction peaks of crystal planes of the CsPbBr.sub.3 crystal. When the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal is synthesized with a Cs/Pb ratio less than or equal to 2.0, the XRD spectrum shows more obvious diffraction noises at about 15.8, 22.4 and 31.9. After being compared with the standard diffraction data, these noises are all diffraction peaks of crystal planes of the CsPbBr.sub.3 crystal. It is thus understood that the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal of the present invention is pure-phase Cs.sub.4PbBr.sub.6 when the Cs/Pb ratio is greater than or equal to 2.5 and less than or equal to 4.5, and is a perovskite luminescent nanocrystal having two phases (Cs.sub.4PbBr.sub.6 and CsPbBr.sub.3) when the Cs/Pb ratio is less than 2.5.

(36) FIG. 7 is an external quantum efficiency (EQE) diagram of a Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal varied with a Cs/Pb ratio according to the present invention. In greater detail, the external quantum efficiencies of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal having different Cs/Pb ratios are identified under excitation of blue light of 460 nm. As shown in FIG. 7, when the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal is synthesized with a Cs/Pb ratio of 4.5, 4.0, 3.5, 3.0, 2.5, 2.0 and 1.0, the external quantum efficiencies of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal are respectively 25.0%, 27.0%, 28.0%, 30.0%, 16.0%, 14.0%, and 12.0%. It is thus understood that when the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal is synthesized with a Cs/Pb ratio greater than or equal to 2.5, the external quantum efficiency of the synthesized Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal is gradually increased as the Cs/Pb ratio is increased. When the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal is synthesized with a Cs/Pb ratio less than 2.5, the external quantum efficiency of the synthesized Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal is rapidly decreased with the decrease of the Cs/Pb ratio.

(37) As can be seen by summarizing the identification results of FIG. 6 and FIG. 7, when the Cs/Pb ratio of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal synthesized by the microemulsion method is greater than 2.5, the crystal continues maintaining the pure phase and the external quantum efficiency is improved with the decrease of the Cs/Pb synthesis ratio. This fact can prove that the three-dimensional halogen(X)-shared CsPbBr.sub.3 clusters, which are caused by the inclusion of cationic defects (for example, may be Cs ion defects, or Pb ion defects, or Cs ion defects and Pb ion defects) in the crystals, are indeed the reason for the high efficiency photoluminescence of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystals. In addition, when the Cs/Pb ratio of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal is less than or equal to 2.5, the crystals generate the CsPbBr.sub.3 impure phase and the external quantum efficiency is rapidly decreased with the decrease of the Cs/Pb synthesis ratio. This fact explains that the luminescence of the Cs.sub.4PbBr.sub.6 perovskite luminescent nanocrystal is not caused by generation of the CsPbBr.sub.3 impure phase.

(38) FIG. 8 depicts a cross-sectional schematic diagram of a light emitting device 800 according to some embodiments of the present invention. As shown in FIG. 8, the light emitting device 800 comprises a light emitting element 810 and a light emitting material 820. In greater detail, the light emitting element 810 can emit blue light or ultraviolet light. For example, the light emitting element 810 may be a light emitting diode chip, a sub-millimeter light emitting diode chip (mini LED chip), or a micro light emitting diode chip (micro LED chip), which can emit blue light having an excitation wavelength from about 420 nm to about 480 nm or ultraviolet light having an excitation wavelength from about 200 nm to about 400 nm. The sub-millimeter light emitting diode chip and the micro light emitting diode chip are smaller than the general light emitting diode chip, for example, the size of the sub-millimeter light emitting diode chip is between about 100 micrometers and about 500 micrometers, and the size of the micro light emitting diode chip is below about 100 micrometers. The light emitting material 820 may comprise the perovskite luminescent nanocrystal as mentioned previously, which receives the blue light or ultraviolet light emitted by the light emitting element 810 to emit first light rays. In greater detail, when the perovskite luminescent nanocrystal is Cs.sub.4PbBr.sub.6, the first light rays that are emitted have a peak wavelength ranged from 500 nm to 540 nm and an FWHM from 10 nm to 30 nm in various embodiments. Since details of the perovskite luminescent nanocrystal are similar to the foregoing, a description in this regard is not provided.

(39) In some embodiments, the light emitting material 820 may further comprise one or more other wavelength converting materials. In greater detail, the light emitting material 820 comprises an inorganic fluorescent powder and an organic fluorescent powder. In greater detail, the inorganic fluorescent powder may be an aluminate fluorescent powder (such as LuYAG, GaYAG, or YAG, etc.), a silicate fluorescent powder, a sulfide fluorescent powder, a nitride fluorescent powder, an oxide fluorescent powder, or a fluoride fluorescent powder, but the present invention is not limited in this regard. The organic fluorescent powder may be selected from a monomolecular structure, a multimolecular structure, an oligomer, or a polymer composed of one or more of the following compounds. Each of the compounds has a perylene group, a benzimidazole group, a naphthalene group, an anthracene group, a phenanthrene group, a fluorene group, a 9-fluorenone group, a carbazole group, a glutarimide group, a 1,3-diphenylbenzene group, a benzopyrene group, a pyrene group, a pyridine group, a thiophene group, a 2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione group and/or a benzimidazole group.

(40) For example, a red fluorescent powder material may be, for example, a manganese-doped red fluoride fluorescent powder that is one or more fluorescent powders selected from the group consisting of the following: (A) A.sub.2[MF.sub.6]: Mn.sup.4+, wherein A is one or more selected from Li, Na, K, Rb, Cs, and NH4, and M comprises one or more selected from Ge, Si, Sn, Ti, and Zr; and (B) A.sub.3[MF.sub.6]: Mn.sup.4+, wherein A is selected from one or more of Li, Na, K, Rb, Cs, and NH4, and M comprises one or more selected from Al, Ga, and In.

(41) In some embodiments, the above one or more wavelength converting materials receive the blue light or ultraviolet light emitted by the light emitting element 810 to emit second light rays. For example, a peak wavelength of the second light rays fall within the red wavelength range.

(42) In various embodiments, the light emitting device 800 may further comprise an encapsulation material 830, and the light emitting material 820 is dispersed in the encapsulation material 830. In greater detail, a material of the encapsulation material 830 may comprise one or more combinations selected from polymethyl methacrylate (PMMA), polyethylene terephthalate (PET), polystyrene (PS), polyethylene (PP), polyamide (PA), polycarbonate (PC), polyimide (PI), polydimethylsiloxane (PDMS), epoxy, and silicone, etc.

(43) In one embodiment, green Cs.sub.4BX.sub.6 perovskite luminescent nanocrystals (for example, Cs.sub.4PbBr.sub.6), red K.sub.2SiF.sub.6: Mn.sup.4+ fluorescent powder, and AB glue for encapsulation are mixed and then dispensed on a blue chip. After curing, the photoluminescence spectrum and color coordinates are measured. The color coordinates in the CIE 1931 XYZ color space are (0.27, 0.24) and the gamut area reaches 129% of NTSC (National Television System Committee). It can be seen that the Cs.sub.4BX.sub.6 perovskite luminescent nanocrystal is a very promising light emitting material at the application end of the backlit displays.

(44) In summary, the manufacturing method for the perovskite luminescent nanocrystal according to the present invention synthesizes the pure-phase Cs.sub.4BX.sub.6 perovskite crystal once. As compared with the common manufacturing method for the perovskite luminescent nanocrystal, it is simpler and more convenient. The perovskite luminescent nanocrystal according to the present invention has good photo-thermal stability and high luminous efficiency. In addition, when the perovskite luminescent nanocrystal described above is applied to a blue light emitting diode or an ultraviolet light emitting diode, it can be used as a light emitting device with high color purity and high quality, which in turn can be applied in a backlit display.

(45) Although the present invention has been described in considerable detail with reference to certain embodiments thereof, other embodiments are possible. Therefore, the spirit and scope of the appended claims should not be limited to the description of the embodiments contained herein.

(46) It will be apparent to those skilled in the art that various modifications and variations can be made to the structure of the present invention without departing from the scope or spirit of the invention. In view of the foregoing, it is intended that the present invention cover modifications and variations of this invention provided they fall within the scope of the following claims and their equivalents.